PAMCX
Price
$90.91
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
PMBJX
Price
$35.36
Change
-$0.03 (-0.08%)
Updated
Sep 18 closing price
Net Assets
20.98B
Interact to see
Advertisement

PAMCX vs PMBJX

PAMCX vs PMBJX Comparison Chart in %
View a ticker or compare two or three
VS
PAMCX vs. PMBJX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Hold and PMBJX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBJX (21B) and PAMCX (20.8B) have equal amount of cash in the bank . PAMCX (0.00) and PMBJX (0.00) have matching dividends . PAMCX was incepted earlier than PMBJX: PAMCX (26 years) vs PMBJX (26 years). PAMCX (1.02) is less costly to investors than PMBJX (0.76). PAMCX is a more actively managed with annual turnover of: 31.50 vs. PMBJX (13.70). PMBJX has a lower initial minimum investment than PAMCX: PMBJX (1000) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : -6.24 vs. PMBJX (-19.27). PMBJX return over 5 years is better than : -10.02 vs. PAMCX (-26.21).
PAMCXPMBJXPAMCX / PMBJX
Total Expense Ratio1.020.76134%
Annual Report Gross Expense Ratio1.020.76134%
Fund Existence26 years26 years-
Gain YTD-0.121-9.2171%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets20.8B21B99%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.24-19.2732%
Returns for 3 years-2.027.84-26%
Returns for 5 years-26.21-10.02262%
Returns for 10 years22.2967.6633%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOUX21.680.02
+0.09%
Goldman Sachs Mid Cap Growth R6
FGDDX43.380.04
+0.09%
Fidelity Advisor® Dividend Growth A
JOHIX29.66-0.01
-0.03%
JOHCM International Select Institutional
SIPIX30.42-0.13
-0.43%
SEI Mid-Cap I (SIMT)
BRSUX16.86-0.08
-0.47%
MFS Blended Research Small Cap Eq R4